Filter By Category
Archives
Share on -
ANPOCOGIN
Generic Name: ANPOCOGIN
ABSTRACT -
Anpocogin is the INN for recombinant nematode anticoagulant protein c2 (rNAPc2), a protein anticoagulant that inhibits the tissue factor/factor VIIa pathway through factor X/Xa binding.
It has been investigated for thrombotic and viral-inflammatory conditions, including studies in COVID-19-associated coagulopathy.
It is not approved for routine clinical use.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- No approved standard dosing regimen is established for this API.
- Doses, route, premedication, monitoring, and dose modifications must follow the applicable clinical-trial or specialist protocol.
- Do not use outside an approved study, compassionate-use program, or authorized regulatory setting.
SIDE EFFECTS–
- Possible side effects may include:
- Bleeding or bruising
- Injection-site reaction
- Anemia or decreased hemoglobin
- Thrombocytopenia
- Headache
- Nausea
- Laboratory coagulation abnormalities
ALLRGIC REACTIONS–
- Hypersensitivity to the active biologic or formulation excipients is possible.
- Symptoms may include rash, urticaria, pruritus, facial swelling, bronchospasm, fever, chills, hypotension, or anaphylaxis.
- Patients with a suspected allergic reaction should stop treatment and seek urgent medical attention.
DRUG INTERACTIONS–
- Anticoagulants, antiplatelet drugs, thrombolytics, and NSAIDs may increase bleeding risk.
- Concomitant invasive procedures increase bleeding risk.
- Monitor coagulation parameters and bleeding signs where protocol requires.
PREAUTIONS–
- Avoid use in active major bleeding unless specifically justified by protocol.
- Assess recent surgery, hemorrhagic stroke, severe thrombocytopenia, and high bleeding risk.
- Use caution in severe hepatic or renal impairment.
- Monitor hemoglobin, platelets, and bleeding symptoms.
WARNINGS –
- Potential for serious or fatal bleeding.
- No approved standard dosing or reversal protocol is established.
- Use only under specialist supervision.
Share on -
. Developed by